|
|
News Breaks | | | | September 13, 2012 | | 09:00 EDT |  | APRI | Apricus Biosciences rises 10.4%
Apricus Biosciences is up 10.4%, or 29c, to $3.09 | |
|
News For APRI From The Last 14 Days Check below for free stories on APRI the last two weeks. |
|
|
| May 23, 2013 | | 08:42 EDT |  | APRI | Apricus Biosciences 6M share Spot Secondary priced at $2.85
 Subscribe for More Information | | | May 22, 2013 | | 18:52 EDT |  | APRI | On The Fly: After Hours Movers
UP AFTER EARNINGS: Hewlett-Packard (HPQ), up 13.4% after reporting second quarter earnings that beat expectations and guiding third quarter and full-year earnings above estimates... Pacific Sunwear (PSUN), up 14.3%. ALSO HIGHER: Merck (MRK), up 0.2% after an FDA advisory panel voted 13-3 in support of the safety of initial doses of its insomnia drug suvorexant. DOWN AFTER EARNINGS: DryShips (DRYS), down 4.7%. ALSO LOWER: Apricus Biosciences (APRI), down 11.5% after filing to sell an ungiven amount of stock... NCI Building Systems (NCS) after being replaced by Cynosure (CYNO) in the S&P 600 as of May 31. | | | 16:03 EDT | | APRI | Apricus Biosciences files to sell common stock, no amount given
Lazard Capital Markets LLC is acting as sole book-running manager for the offering. | |
|
|
|
|
|
|
